Long-term follow-up after tight control of blood pressure in type 2 diabetes

Holman, Rury R., Paul, Sanjoy K., Bethel, M. Angelyn, Neil, H. Andrew W., Matthews, David R.·2008·New England Journal of Medicine

Cited by (761)

Items 201–300 of 761

  1. Controle da pressão arterial em pacientes sob tratamento anti-hipertensivo no Brasil: Controlar Brasil
    Fernando Nobre, Artur Beltrame Ribeiro, Décio Mion Jr · 2010 · Arquivos Brasileiros de Cardiologia
  2. Skin Autofluorescence Based Decision Tree in Detection of Impaired Glucose Tolerance and Diabetes
    Andries Jan Smit, Jitske Martha Smit, Gijs J. Botterblom, Douwe Johannes Mulder · 2013 · PLoS ONE
  3. Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment
    Alina Coutinho Rodrigues Feitosa, Gilson Soares Feitosa-Filho, Fatima Rodrigues Freitas, BERNARDO LEO WAJCHENBERG, Raul Cavalcante Maranhão · 2013 · Lipids in Health and Disease
  4. The vascular complications of diabetes: a review of their management, pathogenesis, and prevention
    Juliet Meir, Lillian Huang, Sumaita Mahmood, Harris Z. Whiteson, Scott Cohen, Wilbert S. Aronow · 2023 · Expert Review of Endocrinology & Metabolism
  5. Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group
    Alexandra Peyser, Nathaniel MacHardy, Freya Tarapore, Jacqueline MacHardy, Leslie Powell, Debbie S. Gipson, Virginia J. Savin, Cynthia G. Pan, Theresa Kump, Suzanne Vento et al. · 2010 · BMC Nephrology
  6. Medical strategies to reduce amputation in patients with Type 2 diabetes
    Rayaz Ahmed Malik, Solomon Hailemariam Tesfaye, Dan Ziegler · 2013 · Diabetic Medicine
  7. Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy
    Fechete, Raul, Heinzel, Andreas, Perco, Paul, Mönks, Konrad, Söllner, Johannes, Stelzer, Gil, Eder, Susanne, Lancet, Doron, Oberbauer, Rainer, Mayer, Gert et al. · 2011 · PROTEOMICS – Clinical Applications
  8. Improving Microvascular Outcomes in Patients with Diabetes through Management of Hypertension
    Janet B. McGill · 2009 · Postgraduate Medicine
  9. Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial
    Kohjiro Ueki, Takayoshi Sasako, Masayuki Kato, Yukiko Okazaki, Sumie Okahata, Hisayuki Katsuyama, Mikiko Haraguchi, Ai Morita, Ken Ohashi, Kazuo Hara et al. · 2016 · BMJ Open Diabetes Research & Care
  10. Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?
    Cai‐Guo Yu, Ning Zhang, Sha‐Sha Yuan, Yan Ma, Longyan Yang, Yingmei Feng, Dong Hong Zhao · 2016 · Stem Cells International
  11. Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes
    Salvatore De Cosmo, Francesca Chiara Viazzi, Pamela Angela Piscitelli, Carlo Bruno Giorda, Antonio Ceriello, Stefano Genovese, Giuseppina Tiziana Russo, Pietro Guida, Paola Fioretto, Roberto Pontremoli · 2016 · Journal of Hypertension
  12. The vicious cycle between transglutaminase 2 and reactive oxygen species in hyperglycemic memory–induced endothelial dysfunction
    Jee‐Yeon Lee, Yeon‐Ju Lee, Hye‐Yoon Jeon, Eun‐Taek Han, Won Sun Park, Seok‐Ho Hong, Young‐Myeong Kim, Kwon‐Soo Ha · 2019 · The FASEB Journal
  13. Pharmacological Treatment of the Pathogenetic Defects in Type 2 Diabetes
    Jeppe Gram, Jan Erik Henriksen, Ellen Grodum, Henning Juhl, Tony Bill Hansen, Christian Fynbo Christiansen, Knud Bonnet Yderstræde, Hans Jørgen Gjessing, Henrik M. Hansen, Vibe Vestergaard et al. · 2010 · Diabetes Care
  14. Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
    W.J. Elliott · 2009 · Yearbook of Cardiology
  15. Primary and Secondary Prevention of Coronary Heart Disease
    J. Michael Gaziano, Paul M. Ridker, Peter Libby · 2012 · Elsevier eBooks
  16. Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone
    Eva Fenwick, Jing Xie, Ryan Eyn Kidd Man, Charumathi Sabanayagam, Lyndell L. Lim, Gwyn Rees, Tien Yin Wong, Ecosse Luc Lamoureux · 2017 · PLoS ONE
  17. Clinical features and therapeutic perspectives on hypertension in diabetics
    Shigehiro Katayama, M Hatano, Masashi Issiki · 2018 · Hypertension Research
  18. The Visceral Adiposity Index Is a Predictor of Incident Chronic Kidney Disease: A Population-Based Longitudinal Study
    Ryo Bamba, Takuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, Akihiro Obora, Takao Kojima, Michiaki Fukui · 2020 · Kidney & Blood Pressure Research
  19. Cost-Effectiveness of the Diabetes Care Protocol, a Multifaceted Computerized Decision Support Diabetes Management Intervention That Reduces Cardiovascular Risk
    Frits G.W. Cleveringa, Paco M J Welsing, Maureen van den Donk, Kees J. Gorter, Louis Wilhelmus Niessen, Guy E.H.M. Rutten, Ken Redekop · 2009 · Diabetes Care
  20. Activation of Transient Receptor Potential Channel Vanilloid 4 by DPP-4 (Dipeptidyl Peptidase-4) Inhibitor Vildagliptin Protects Against Diabetic Endothelial Dysfunction
    Peng Gao, Li Li, Xiao Wei, Miao Wang, Yangning Hong, Hao Wu, Yanjia Shen, Tianyi Ma, Xing Wei, Qin Zhang et al. · 2019 · Hypertension
  21. Vascular memory: can we broaden the concept of the metabolic memory?
    György Jermendy · 2012 · Cardiovascular Diabetology
  22. Can a Protocol for Glycaemic Control Improve Type 2 Diabetes Outcomes After Gastric Bypass?
    Wiebke Kristin Fenske, Dimitri J. Pournaras, Erlend Tuseth Aasheim, Alexander Dimitri Miras, Nicola Scopinaro, Samantha Scholtz, Carel Wynand le Roux · 2011 · Obesity Surgery
  23. Metabolic transcriptional memory
    Poonam Bheda · 2020 · Molecular Metabolism
  24. Renal tubular Bim mediates the tubule-podocyte crosstalk via NFAT2 to induce podocyte cytoskeletal dysfunction
    Chunmei Xu, Xiaojun Zhou, Tianyue Xie, Yuan Zhou, Qian Zhang, Shan Jiang, Rui Zhang, Lin Liao, Jianjun Dong · 2020 · Theranostics
  25. Taking small steps towards targets - perspectives for clinical practice in diabetes, cardiometabolic disorders and beyond
    Alain Golay, E. Brock, R. Gabriel, T. Konrad, Nebojsa M. Lalic, Martine Laville, Geltrude Mingrone, John R. Petrie, Tra‐Mi Phan, Kirsi Hannele Pietiläinen et al. · 2013 · International Journal of Clinical Practice
  26. Antihypertensive Therapy in Diabetes: The Legacy Effect and RAAS Blockade
    Massimo Volpe, Francesco Cosentino, Giuliano Tocci, Francesca Palano, Francesco Paneni · 2011 · Current Hypertension Reports
  27. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system
    Lukas Kaiser, Thomas Beister, Andrea Wiese, Jasper von Wedel, Felix Meincke, Felix Kreidel, Andreas Busjahn, Karl‐Heinz Kück, Martin Bergmann · 2014 · EuroIntervention
  28. Duration of type 2 diabetes strongly predicts all-cause and cardiovascular mortality in people referred for coronary angiography
    Günther Silbernagel, Silke Rosinger, Tanja B. Grammer, Marcus Edi Kleber, Bernhard Rudolf Winkelmann, Bernhard Otto Boehm, Winfried März · 2012 · Atherosclerosis
  29. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case‐control study
    Laurent Azoulay, Verena Schneider‐Lindner, Sophie Dell’Aniello, Alicia Schiffrin, Samy Suissa · 2010 · Pharmacoepidemiology and Drug Safety
  30. Benefits of Early Hypertension Control on Cardiovascular Outcomes in Patients With Diabetes
    Patrick J. O’Connor, Gabriela Vazquez‐Benitez, Julie A. Schmittdiel, Emily D. Parker, Nicole K. Trower, JAY R. DESAI, Karen L. Margolis, David J. Magid · 2012 · Diabetes Care
  31. Hyperglycemic conditions modulate connective tissue reorganization by human vascular smooth muscle cells through stimulation of hyaluronan synthesis
    Annele Sainio, Tiina A. Jokela, Markku Tammi, Hannu Järveläinen · 2010 · Glycobiology
  32. Use of Medical Services and Medicines Attributable to Diabetes in Sub-Saharan Africa
    Jonathan Betz Brown, Kaushik Laxmidas Ramaiya, Stéphane Besançon, Paul Rheeder, Clarisse MAPA-TASSOU, Jean Claude Mbanya, Katarzyna Kissimova‐Skarbek, Eva Wangechi Njenga, Eva Wangui Muchemi, Harrison Kiambuthi Wanjiru et al. · 2014 · PLoS ONE
  33. Head-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an assessor-blinded, parallel group and randomised trial
    M. Ried-Larsen, R. Christensen, K. B. Hansen, Mette Y. Johansen, M. Pedersen, M. Zacho, L. Hansen, Katja Kofoed, K. Thomsen, M. S. Jensen et al. · 2015 · BMJ Open
  34. Biochemical Markers of In Vivo Hepatotoxicity
    Arika WM, Dorothy Wavinya Nyamai · 2016 · Journal of Clinical Toxicology
  35. Middle-Aged and Older Patients With Left Ventricular Hypertrophy: Higher Mortality With Drug Treated Systolic Blood Pressure Below 130 mm Hg
    Sondre Heimark, Maria H. Mehlum, Giuseppe Mancia, Camilla Lund Søraas, Knut Liestøl, Kristian Wachtell, Anne Cecilie K. Larstorp, Morten Rostrup, Julian Eek Mariampillai, Sverre Erik Kjeldsen et al. · 2023 · Hypertension
  36. Stroke in the patient with diabetes (part 1) – Epidemiology, etiology, therapy and prognosis
    David S.H. Bell, Edison Gonçalves · 2020 · Diabetes Research and Clinical Practice
  37. Hypertension: Is It Overtreated in the Elderly?
    John Edward Morley · 2010 · Journal of the American Medical Directors Association
  38. Effect of acute hyperglycaemia, long‐term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics
    Antonio Ceriello, Katherine Esposito, Michael A. Ihnat, Jessica E. Thorpe, Dario Giugliano · 2009 · Diabetic Medicine
  39. Corporate Logic in Clinical Care: The Case of Diabetes Management
    Linda M. Hunt, Hannah S. Bell, Anna C. Martinez‐Hume, Funmi Odumosu, Heather Howard · 2019 · Medical Anthropology Quarterly
  40. Implementing changes in clinical practice to improve the management of Crohn's disease
    Remo Panaccione, Toshifumi Hibi∥, Laurent Peyrin‐Biroulet, Stefan Schreiber · 2012 · Journal of Crohn s and Colitis
  41. Novel insights into metabolic sequelae of obstructive sleep apnoea: A link between hypoxic stress and chronic diabetes complications
    Mária Pallayová, Dev Banerjee, Shahrad Taheri · 2014 · Diabetes Research and Clinical Practice
  42. Research strategies in treatment of hypertension: value of retrospective real-life data
    Giovanni Corrao, Giuseppe Mancia · 2021 · European Heart Journal
  43. Impact of acute hyperglycaemia on endothelial function and retinal vascular reactivity in patients with Type 2 diabetes
    M. V. Chittari, Philip G. McTernan, Nahla Mohammed Bawazeer, Kostas Constantinides, Miryam Ciotola, Joseph Paul O’Hare, Sudhesh Kumar, Antonio Ceriello · 2010 · Diabetic Medicine
  44. “Mild dysglycemia” in type 2 diabetes: to be neglected or not?
    L. Monnier, C Colette, Sylvie Dejager, David R. Owens · 2014 · Journal of Diabetes and its Complications
  45. Ameliorative impact of Morus alba leaves’ aqueous extract against embryonic ophthalmic tissue malformation in streptozotocin-induced diabetic rats
    Adel M. A. Assiri, Mohamed E. El‐Beeh, Ali H. Amin, Mohamed Fawzy Ramadan · 2017 · Biomedicine & Pharmacotherapy
  46. Poor self-rated health is not associated with a high total allostatic load in type 2 diabetic patients – But high blood pressure is
    Carlsson, A.C., Nixon Andreasson, A., Wändell, P.E. · 2011 · Diabetes & Metabolism
  47. Changes in Albumin Excretion in the Diabetes Prevention Program
    Diabetes Prevention Program Research Group · 2009 · Diabetes Care
  48. Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study
    Björn Rathsman, Kerstin Jensen‐Urstad, Thomas Nyström · 2014 · Diabetologia
  49. Thresholds of Ambulatory Blood Pressure Associated With Chronic Complications in Type 2 Diabetes
    Claudia R.L. Cardoso, Nathalie Carvalho Leite, Elizabeth Silaid Muxfeldt, Gil Fernando Salles · 2011 · American Journal of Hypertension
  50. Evidence-Based Treatment of Diabetic Macular Edema
    Rasha Barham, Hala El Rami, Jennifer K. Sun, Paolo Sandico Silva · 2017 · Seminars in Ophthalmology
  51. Diabetes-related end-stage renal disease in Austria 1965–2013
    Friedrich C. Prischl, Martin Auinger, Marcus D. Säemann, Gert J. Mayer, Alexander R. Rosenkranz, Manfred Wallner, Reinhard Kramar · 2015 · Nephrology Dialysis Transplantation
  52. Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide
    Renate E. van Genugten, Daniël H. van Raalte, Michaëla Diamant · 2009 · Diabetes Research and Clinical Practice
  53. Effects of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin on Blood Pressure in Hypertensive Patients with Type 2 Diabetes Mellitus
    Shinji Kishimoto, Yoshihiko Kinoshita, Takeshi Matsumoto, Tatsuya Maruhashi, Masato Kajikawa, Shogo Matsui, Haruki Hashimoto, Yuji Takaeko, Yasuki Kihara, Kazuaki Chayama et al. · 2019 · American Journal of Hypertension
  54. Polypharmacy among people living with type 2 diabetes mellitus in rural communes in Vietnam
    Bùi Thị Huyền Diệu, Bai Xuan Nguyen, Dat Cong Truong, Dan Wolf Meyrowitsch, Jens Søndergaard, Tine M Gammeltoft, Ib Christian Bygbjerg, Nielsen Jannie · 2021 · PLoS ONE
  55. Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?
    Aowen Zhuang, Josephine Maree Forbes · 2016 · Glycoconjugate Journal
  56. Evaluating the implementation of a national clinical programme for diabetes to standardise and improve services: a realist evaluation protocol
    Sheena McHugh, ML Tracey, Fiona Riordan, Kate O’Neill, Nicholas Mays, Patricia M. Kearney · 2015 · Implementation Science
  57. Cause-of-Death Trends for Diabetes Mellitus over 10 Years
    Su Kyung Park, Mi-Kyoung Park, Ji Hye Suk, Mi-Kyung Kim, Yong Ki Kim, In Ju Kim, Yang Ho Kang, Kwang Jae Lee, Hyun Seung Lee, Chang Won Lee et al. · 2009 · Korean Diabetes Journal
  58. Alogliptin in Patients with Type 2 Diabetes Receiving Metformin and Sulfonylurea Therapies in the EXAMINE Trial
    William B. White, Simon R. Heller, Christopher Paul Cannon, Heena Howitt, Kamlesh Khunti, Richard M. Bergenstal · 2018 · The American Journal of Medicine
  59. Effects of High Blood Pressure on Cardiovascular Disease Events Among Chinese Adults With Different Glucose Metabolism
    Jingyan Tian, Chang‐Sheng Sheng, Weihong Sun, Xiaomin Song, Haiyan Wang, Qifang Li, Wenyi Li, Weiqing Wang · 2018 · Diabetes Care
  60. Effect of SGLT-2 inhibitor, empagliflozin, on blood pressure reduction in Chinese elderly hypertension patients with type 2 diabetes and its possible mechanisms
    Lan Cheng, Qianyu Fu, Longhua Zhou, Yuqin Fan, Fenfen Liu, Yuanyuan Fan, Xin Zhang, Weiqing Lin, Xiaohe Wu · 2022 · Scientific Reports
  61. The Role of Vasodilating β-Blockers in Patients with Hypertension and the Cardiometabolic Syndrome
    Addison A. Taylor, George L. Bakris · 2010 · The American Journal of Medicine
  62. Quality improvement in practice: improving diabetes care and patient outcomes in Aboriginal Community Controlled Health Services
    Alice Stoneman, David N. Atkinson, Maureen E. Davey, Julia V. Marley · 2014 · BMC Health Services Research
  63. Blood Pressure Management in Patients With Diabetes
    Amanda H. Salanitro, Christianne L. Roumie · 2010 · Clinical Diabetes
  64. Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapies
    Sophia Zoungas, Anushka A Patel · 2010 · Annals of the New York Academy of Sciences
  65. Residual risk for secondary ischemic events in patients with atherothrombotic disease: Opportunity for future improvements in patient care
    Carl J. Pepine · 2010 · Annals of Medicine
  66. Divergent Effects of Various Diabetes Drugs on Cardiovascular Prognosis
    David S.H. Bell, Harshal Patil, James Henry O’Keefe · 2013 · Reviews in Cardiovascular Medicine
  67. The influence of diabetes distress on digital interventions for diabetes management in vulnerable people with type 2 diabetes: A qualitative study of patient perspectives
    Anne Sophie Mathiesen, Thordis Thomsen, Tonny Joran Jensen, Charlotte Schiøtz, Henning Langberg, Ingrid Egerod · 2017 · Journal of Clinical & Translational Endocrinology
  68. A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication
    Barrett W. Jeffers, Jeffery L. Robbins, Rahul Bhambri, Dalia Wajsbrot · 2015 · American Journal of Therapeutics
  69. Long-term follow-up of lipid-lowering trials
    Chris J. Packard, Ian Ford · 2015 · Current Opinion in Lipidology
  70. Spousal cardiometabolic risk factors and incidence of type 2 diabetes: a prospective analysis from the English Longitudinal Study of Ageing
    Jannie Nielsen, Ádám Hulmán, Daniel R. Witte · 2018 · Diabetologia
  71. Long-term clinical experience with zofenopril
    Claudio Borghi, Stefano Bacchelli, Daniela Degli Esposti · 2012 · Expert Review of Cardiovascular Therapy
  72. Noninferiority Effects on Glycemic Control and β-Cell Function Improvement in Newly Diagnosed Type 2 Diabetes Patients: Basal Insulin Monotherapy Versus Continuous Subcutaneous Insulin Infusion Treatment
    Longyi Zeng, Hongyun Lu, Hongrong Deng, Panwei Mu, Xiaofeng Li, Manman Wang · 2011 · Diabetes Technology & Therapeutics
  73. The Role of Glucosamine-Induced ER Stress in Diabetic Atherogenesis
    Daniel R. Beriault, Geoff H. Werstuck · 2012 · Experimental Diabetes Research
  74. The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
    Viswanathan Mohan, Mark Emmanuel Cooper, David Richard Matthews, Kamlesh K. Khunti · 2019 · Diabetes Therapy
  75. Systemic medical management of diabetic retinopathy
    Lingam Gopal, Tien Yin Wong · 2013 · Middle East African Journal of Ophthalmology
  76. Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
    Young Ki Lee, Sun Ok Song, Kwang Joon Kim, Yongin Cho, YounJeong Choi, Yujung Yun, Byung‐Wan Lee, Eun Seok Kang, Bong Soo, Hyun Chul Lee · 2013 · Diabetes & Metabolism Journal
  77. Perspectives on cardiovascular effects of incretin-based drugs: From bedside to bench, return trip
    Michaela Luconi, Giulia Cantini, Antonio Ceriello, Edoardo Mannucci · 2017 · International Journal of Cardiology
  78. What matters in ADVANCE and ADVANCE‐ON
    Pavel Hamet · 2011 · Diabetes Obesity and Metabolism
  79. Nutrition, Epigenetic Mechanisms, and Human Disease
    Nilanjana Maulik, Gautam Maulik · 2010 · CRC Press eBooks
  80. Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea
    Da Hea Seo, Shinae Kang, Yong‐ho Lee, Jung Yoon Ha, Jong Suk Park, Byung‐Wan Lee, Eun Seok Kang, Chul Woo Ahn, Bong Soo · 2019 · Endocrinology and Metabolism
  81. Optimal treatment of diabetic retinopathy
    Hans‐Peter Hammes · 2013 · Therapeutic Advances in Endocrinology and Metabolism
  82. Follow-up of Intensive Glucose Control in Type 2 Diabetes
    Søren Søgaard Lund, Peter R Rossing, Allan Arthur Vaag · 2009 · New England Journal of Medicine
  83. Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk
    Magdalena del Rocío Sevilla-González, Jordi Merino, Hortensia Moreno-Macías, Rosalba Rojas, Donají Gómez‐Velasco, Alisa Knodle Manning · 2021 · Cardiovascular Diabetology
  84. Pathophysiology, Prevention and Management of Chronic Kidney Disease in the Hypertensive Patient With Diabetes Mellitus
    Anna Solini, Ele Ferrannini · 2011 · Journal of Clinical Hypertension
  85. Room for improvement in diabetes care among First Nations in northern Quebec (Eeyou Istchee): reasonable management of glucose but poor management of complications
    Mariam Naqshbandi Hayward, Elena Kuzmina, David A. Dannenbaum, Jill Torrie, Jennifer Huynh, Stewart B. Harris · 2012 · International Journal of Circumpolar Health
  86. Cost‐effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen‐detected Type 2 diabetes: analysis of the ADDITION ‐ UK cluster‐randomized controlled trial
    L. Tao, Ed Wilson, Nicholas J. Wareham, Annelli Sandbæk, Guy E.H.M. Rutten, T. Lauritzen, Kamlesh K. Khunti, Melanie Jane Davies, K. Borch‐Johnsen, Simon J. Griffin et al. · 2015 · Diabetic Medicine
  87. Importance of Metabolic Memory in the Development of Vascular Complications in Diabetic Patients
    Pastor Luna, Verónica Guarner‐Lans, José María Farías, Guadalupe Hernández‐Pacheco, Martín Martínez · 2016 · Journal of Cardiothoracic and Vascular Anesthesia
  88. Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors
    Jordi Merino, Kathleen A. Jablonski, Josep Maria Mercader, Steven E. Kahn, Ling Chen, Maegan V. Harden, Linda M. Delahanty, Maria Rosario G. Araneta, Geoffrey A. Walford, Suzanne B.R. Jacobs et al. · 2019 · Diabetes
  89. What should be the antihypertensive drug of choice in diabetic patients and should we avoid drugs that increase glucose levels? Pro and Cons
    Standl, Eberhard, Erbach, Michael, Schnell, Oliver · 2012 · Diabetes/Metabolism Research and Reviews
  90. Clinical guidelines of the Russian Medical Society on arterial Hypertension (RSH) and the Eurasian association of Cardiologists (EaC) for the diagnosis and treatment of arterial hypertension (2024)
    Irina Evgen'evna Chazova, Чихладзе Новелла Михайловна, Nataliya V. Blinova, Аксенова Анна Владимировна, Tatiana A. Alekseeva, Lali G. Ambatiello, Yu. А. Balanova, Anna E. Bragina, Nikolai M. Danilov, O. M. Drapkina et al. · 2024 · Systemic Hypertension
  91. Replication of Genetic Loci Implicated in Diabetic Retinopathy
    Annie K. McAuley, Jie Jin Wang, Mohamed Dirani, Paul Connell, Ecosse Luc Lamoureux, Alex William Hewitt · 2014 · Investigative Ophthalmology & Visual Science
  92. Critical roles of miR-21 in promotions angiogenesis: friend or foe?
    Mohamed J. Saadh, Nisreen Yasir Jasim, Mareb Hamed Ahmed, Suhas Ballal, Abhishek Kumar, Shikha Atteri, Raghav Vashishth, Jasur Alimdjanovich Rizaev, Ahmed Alhili, Mahmood Jasem Jawad et al. · 2025 · Clinical and Experimental Medicine
  93. Preventive cardiology and cardiac rehabilitation programmes in women
    Guy Lloyd · 2009 · Maturitas
  94. Is a legacy effect possible in IgA nephropathy?
    Rosanna Coppo · 2013 · Nephrology Dialysis Transplantation
  95. DECREASED RETINAL CAPILLARY DENSITY IS ASSOCIATED WITH A HIGHER RISK OF DIABETIC RETINOPATHY IN PATIENTS WITH DIABETES
    Cecília Nóra Czakó, Gábor László Sándor, Mónika Ecsedy, Zsuzsa Récsán, Hajnalka Horváth, Zsuzsanna Szepessy, Zoltán Zsolt Nagy, Illés Kovács · 2018 · Retina
  96. Using glycated haemoglobin testing to simplify diabetes screening in remote Aboriginal Australian health care settings
    Julia V. Marley, May Sian Oh, Nyssa T Hadgraft, Sally Singleton, Kim Isaacs, David N. Atkinson · 2015 · The Medical Journal of Australia
  97. Weight and blood pressure response to weight management and sibutramine in diabetic and non‐diabetic high‐risk patients: an analysis from the 6‐week lead‐in period of the sibutramine cardiovascular outcomes (SCOUT) trial
    Luc F. Van Gaal, Ian Douglas Caterson, Walmir Ferreira Coutinho, Nick Finer, Aldo Pietro Maggioni, Arya Mitra Sharma, Christian Torp-Pedersen, H. Ge, S. A. Moran, G Shepherd et al. · 2009 · Diabetes Obesity and Metabolism
  98. Long non-coding RNAs–towards precision medicine in diabetic kidney disease?
    Usha Panchapakesan, Carol A. Pollock · 2016 · Clinical Science
  99. Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes
    Luigi Gnudi, David J.A. Goldsmith · 2010 · F1000 Medicine Reports
  100. Associations between Carotid Artery Wall Thickness and Cardiovascular Risk Factors Using Multidetector CT
    Luca Saba, Roberto Sanfilippo, Roberto Montisci, Giorgio Mallarini · 2010 · American Journal of Neuroradiology